Telbivudine
Telbivudine is a Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of telbivudine is as a Nucleoside Reverse Transcriptase Inhibitor. The chemical classification of telbivudine is Nucleoside Analog. (In Vitro) :Telbivudine reverses B19V-induced dysregulation of BIRC3, thus, intervening in the apoptosis pathway and protecting susceptible cells from cell death.
Product Specifications
CAS Number
3424-98-4
Product Name Alternative
LDT 600 | LD-T600 | LDT600 | Telbivudine | Tyzeka | Epavudine
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Ethanol: 2 mg/mL warmed (8.25 mM) ; Water: 48 mg/mL warmed (198.15 mM) ; DMSO: 48 mg/mL warmed (198.15 mM)
Smiles
O=C1NC (C (C) =CN1[C@@H]2C[C@H] ([C@H] (CO) O2) O) =O
Molecular Formula
C10H14N2O5
Molecular Weight
242.23
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1- ((2S,4R,5S) -4-hydroxy-5- (hydroxymethyl) tetrahydrofuran-2-yl) -5-methylpyrimidine-2,4 (1H,3H) -dione
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human FAM160A2 shRNA (UAS) - Lentiviral human FAM160A2 shRNA (UAS, iRFP) (25)
LRRC8A (Leucine Rich Repeat Containing 8 Family, Member A, FLJ10337, FLJ41617, KIAA1437, LRRC8) (MaxLight 650)
Lentiviral mouse Kcnn1 shRNA (UAS) - Lentiviral mouse Kcnn1 shRNA (UAS) plasmid
CARF (CDKN2A Interacting Protein, CARF, FLJ20036) (APC)